China
上海阶梯医疗科技有限公司 is a Health Care startup based in China, pioneering the development of a full-stack implantable brain-machine interface system. Established in 2021, the company's primary focus is on neurotechnology and neuroscience, particularly in the field of brain-machine interface.
The company recently secured a Series A investment on 30 December 2022 from prominent investors, including OrbiMed and Oriza Seed Capital (Oriza Yuandian). This significant investment indicates the growing interest and potential in the innovative technologies being developed by 上海阶梯医疗科技有限公司.
